Dieter Rosskopf

Author PubWeight™ 54.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 2008 4.67
2 Cohort profile: the study of health in Pomerania. Int J Epidemiol 2010 4.38
3 Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups. PLoS Genet 2010 3.21
4 A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 2007 2.75
5 Cluster headache: clinical presentation, lifestyle features, and medical treatment. Headache 2006 1.86
6 A genome-wide association study identifies three loci associated with mean platelet volume. Am J Hum Genet 2008 1.81
7 Associations between the oxytocin receptor gene (OXTR) and affect, loneliness and intelligence in normal subjects. Prog Neuropsychopharmacol Biol Psychiatry 2009 1.77
8 Inverse association between serum free thyroxine levels and hepatic steatosis: results from the Study of Health in Pomerania. Thyroid 2012 1.62
9 Serotonin transporter gene (SLC6A4) promoter polymorphisms and the susceptibility to posttraumatic stress disorder in the general population. Am J Psychiatry 2009 1.36
10 Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes 2009 1.28
11 Meta-analysis of the INSIG2 association with obesity including 74,345 individuals: does heterogeneity of estimates relate to study design? PLoS Genet 2009 1.18
12 Direct stimulation of receptor-controlled phospholipase D1 by phospho-cofilin. EMBO J 2007 1.14
13 Cyclic AMP-dependent and Epac-mediated activation of R-Ras by G protein-coupled receptors leads to phospholipase D stimulation. J Biol Chem 2006 1.12
14 Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation 2006 1.09
15 Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations. J Clin Endocrinol Metab 2009 1.04
16 Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men. Int J Androl 2009 1.04
17 Survey of Neonates in Pomerania (SNiP): a population-based birth study--objectives, design and population coverage. Paediatr Perinat Epidemiol 2010 1.00
18 Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer. Eur Urol 2005 0.93
19 Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse. Prog Neuropsychopharmacol Biol Psychiatry 2011 0.93
20 Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1. Pharmacogenet Genomics 2008 0.91
21 Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin. Drug Metab Dispos 2009 0.89
22 Rap2B-dependent stimulation of phospholipase C-epsilon by epidermal growth factor receptor mediated by c-Src phosphorylation of RasGRP3. Mol Cell Biol 2004 0.89
23 Influence of DRD2 and ANKK1 genotypes on apomorphine-induced growth hormone (GH) response in alcohol-dependent patients. Prog Neuropsychopharmacol Biol Psychiatry 2009 0.89
24 Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme. BMC Cancer 2013 0.89
25 Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil. Drug Metab Dispos 2010 0.88
26 Associations between the oxytocin receptor gene (OXTR) and "mind-reading" in humans--an exploratory study. Nord J Psychiatry 2012 0.87
27 Reference ranges for serum dehydroepiandrosterone sulfate and testosterone in adult men. J Androl 2008 0.85
28 Predictors of acute treatment response among patients with cluster headache. Headache 2007 0.85
29 Inhibition of glycogen synthase kinase 3beta prevents peroxide-induced collapse of mitochondrial membrane potential in rat ventricular myocytes. Clin Exp Pharmacol Physiol 2010 0.84
30 Disposition and sterol-lowering effect of ezetimibe are influenced by single-dose coadministration of rifampin, an inhibitor of multidrug transport proteins. Clin Pharmacol Ther 2006 0.83
31 Role of MRP4 (ABCC4) in platelet adenine nucleotide-storage: evidence from patients with delta-storage pool deficiencies. Am J Pathol 2010 0.83
32 Comment on "Genetically determined differences in learning from errors". Science 2008 0.82
33 Moderation of adult depression by the serotonin transporter promoter variant (5-HTTLPR), childhood abuse and adult traumatic events in a general population sample. Am J Med Genet B Neuropsychiatr Genet 2012 0.82
34 Alcohol consumption is associated with an interaction between DRD2 exon 8 A/A genotype and self-directedness in males. Neuropsychobiology 2007 0.81
35 Concentration of the macrolide antibiotic tulathromycin in broncho-alveolar cells is influenced by comedication of rifampicin in foals. Naunyn Schmiedebergs Arch Pharmacol 2009 0.81
36 Association study of the G-protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer. World J Urol 2005 0.80
37 Gastric inhibitory polypeptide receptor: association analyses for obesity of several polymorphisms in large study groups. BMC Med Genet 2009 0.79
38 Association between migraine and the G1246A polymorphism in the hypocretin receptor 2 gene. Headache 2007 0.79
39 Exploring warfarin pharmacogenomics with the extreme-discordant-phenotype methodology: impact of FVII polymorphisms on stable anticoagulation with warfarin. Eur J Clin Pharmacol 2009 0.78
40 Aminoglycoside-induced suppression of CYP2C19*3 premature stop codon. Pharmacogenet Genomics 2011 0.78
41 Investigation of the Lith6 candidate genes APOBEC1 and PPARG in human gallstone disease. Liver Int 2007 0.78
42 MTHFR 677C>T polymorphism and cluster headache. Headache 2010 0.77
43 β-blocker therapy and heart rate control during exercise testing in the general population: role of a common G-protein β-3 subunit variant. Pharmacogenomics 2010 0.75
44 Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1. Br J Clin Pharmacol 2015 0.75
45 Bi-allelic and tri-allelic 5-HTTLPR polymorphisms and triptan non-response in cluster headache. J Headache Pain 2014 0.75
46 Common variants in the G protein beta3 subunit gene and thyroid disorders in a formerly iodine-deficient population. Thyroid 2009 0.75